Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver(Harvard University), J. Keith Joung(Massachusetts General Hospital), Ved V. Topkar(Massachusetts General Hospital), Zongli Zheng(City University of Hong Kong), Martin J. Aryee(Johns Hopkins University), Randall T. Peterson(University of Utah), Andrew P. W. Gonzales(Massachusetts General Hospital), Michelle S. Prew(Massachusetts General Hospital), Jing-Ruey Joanna Yeh(Harvard University), Shengdar Q. Tsai(Harvard University), Nathalie T. Nguyen(Massachusetts General Hospital), Zhuyun Li(Massachusetts General Hospital)
Cited by 1,664
Related Papers
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
|Nature Biotechnology|2013|3.3k
CRISPR-Cas systems for editing, regulating and targeting genomes
|Nature Biotechnology|2014|3.2k
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k